What If Cancer Could Be Remembered Instead of Eradicated?
What if cancer didn’t always have to be destroyed to be controlled?
What if, instead, the immune system could remember cancer the way it remembers a virus, quietly watching, recognizing, and responding years—or even decades—later?
That question sits at the center of a remarkable new study revisiting a breast cancer vaccine trial conducted more than 20 years ago. And the results are, frankly, astonishing.
In a new episode of Causes or Cures, I spoke with Dr. Zachary Hartman, the lead researcher who helped uncover something almost unheard of in oncology: durable immune memory against cancer lasting more than two decades.
Not in mice.
Not in theory.
In real women.
And all of them are still alive.
A Small Trial With a Very Long Shadow
More than two decades ago, a small group of women with advanced breast cancer enrolled in an experimental vaccine trial. The goal wasn’t cure in the way we usually think of it. The vaccine was designed to teach the immune system to recognize cancer cells—to see them as targets rather than background noise.
At the time, expectations were modest. Cancer vaccines had a long history of mixed results, and long-term follow-up of patients was rare.
Fast forward 20+ years.
When researchers tracked down participants from the original trial, they made a discovery that stopped them in their tracks:
Every single woman was still alive.
Even more surprising was what they found when they looked at their blood.
Immune Memory That Refused to Fade
By analyzing blood samples decades after vaccination, Dr. Hartman and his team discovered that these women still carried immune cells capable of recognizing their cancer.
In other words, their immune systems hadn’t forgotten.
This kind of long-lasting immune memory is something we commonly associate with infections like measles or smallpox—but cancer? That’s different. Tumors evolve. They hide. They suppress immune responses.
And yet, these immune cells persisted.
In the episode, Dr. Hartman walks through what this immune memory looked like, and why it matters.
The Role of CD27 and the Power of “Helper” T Cells
One of the most intriguing findings involved CD27-positive immune cells, a subset associated with long-lived immune responses.
Rather than focusing only on the classic “killer” CD8 T cells, this research highlights the potential importance of helper CD4 T cells—cells that coordinate, sustain, and strengthen immune responses over time.
In animal studies, the team tested what happened when they combined a cancer vaccine with an antibody that boosts CD27 signaling. The result? Stronger, more durable immune responses that improved tumor control in mice.
It raises a provocative question:
What if sustaining immune memory matters more than simply attacking tumors aggressively?
Can Cancer Become a Managed Disease?
Throughout the conversation, Dr. Eeks and Dr. Hartman explore a bigger idea that challenges how we talk about cancer altogether.
Instead of framing success as total eradication, what if the goal were long-term immune surveillance?
Not cure versus failure—but control.
They discuss:
- Why translating results from mice to humans is so difficult
- Whether immune memory like this could apply to other cancers
- How cancer vaccines differ fundamentally from preventive vaccines
- What this research might mean in a post-pandemic world where the public understands immune memory better than ever
And perhaps most importantly, Dr. Hartman shares the one key message he hopes the public takes away from this work.
Why This Research Matters Now
Cancer immunotherapy has already changed oncology, but this study pushes the conversation further—toward time, memory, and durability.
It asks us to rethink what success looks like.
And it suggests that the immune system, when properly trained, may be capable of far more patience—and persistence—than we once believed.
Listen to the Full Conversation
This episode of Causes or Cures goes deep into the science while keeping the explanations grounded and accessible. If you’re curious about cancer vaccines, immune memory, or the future of immunotherapy, this is a conversation worth hearing.
🎧 Listen to the episode here
About the Guest
Dr. Zachary C. Hartman is an Associate Professor at Duke University in the Departments of Surgery, Pathology, and Integrative Immunobiology. He serves as Director of the Center for Applied Therapeutics and is a member of the Cellular and Molecular Biology and Genetics and Genomics programs.
Dr. Hartman earned his undergraduate degree from Northwestern University and completed his PhD at Duke University, followed by postdoctoral training in tumor immunology and breast oncology at Duke and the MD Anderson Cancer Center. Since returning to Duke in 2012, his research has focused on tumor immunology and the development of cancer immunotherapies, including therapeutic vaccines, immune agonists, checkpoint inhibitors, antibody-based therapies, and strategies to stimulate anti-tumor immune responses.
Help Support the Podcast!
Causes or Cures is for people who want to understand public health and medical research without being talked down to, scared, or sold something. Each episode is grounded in real research and thoughtful conversations with experts, handled carefully and without hype.
The show prioritizes editorial independence and stays free and accessible thanks to listener support, which helps cover the behind-the-scenes work that makes each episode possible.
If you have ever finished an episode feeling clearer, more informed, or pleasantly surprised by something you learned, becoming a monthly supporter is a simple way to help keep the show going.
No paywalls. No fear tactics. No miracle cures.
Just careful conversations about health, with the occasional weird or funny detour.
Thank you! – Eeks
**********************************************************************************************************Other gems from the blog to check out:
Can probiotics help protect you from microplastics? Find out here!
Are Poinsettias really poisonous?
Don’t forget to subscribe to my newsletter! :)